Siemens Healthineers to Expand its Newark, DE Laboratory Diagnostics Manufacturing Facility

• Siemens Healthineers will invest more than $32M in the company's laboratory diagnostics manufacturing facility located in Newark, DE.
• The project is expected to take 24 months.
• The goal of the project is to expand the company's manufacturing capabilities at the facility to accommodate growth in its manufacturing operations for the Atellica® Solution.

The investment extends over 24 months and will enable the company to position in Delaware manufacturing capabilities for more than 20 diagnostic tests. This project is part of an initiative to drive greater efficiency, productivity, and stability across the company's diagnostics supply chain.

“The Glasgow manufacturing facility expansion will further increase our manufacturing footprint in the United States—the largest healthcare market in the world,” said Deepak Nath, PhD, President of Laboratory Diagnostics, Siemens Healthineers. “As part of the expansion, we will relocate important test manufacturing to this facility, which will streamline some of our processes and further improve the efficiency with which we can deliver these important tests to healthcare providers and their patients.”

The Newark, DE facility employs more than 1,300 employees and manufactures more than 120 assays that run on certain instrument platforms, including the Atellica® Solution, ADVIA® Chemistry, Dimension®, Dimension Vista®, Syva Drug Testing, and Stratus® CS instruments—providing tests that help physicians diagnose, monitor, and/or treat diseases.

The Glasgow manufacturing facility is one of several manufacturing facilities Siemens Healthineers operates for its diagnostics portfolio.